<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Cosmos Health Inc. — News on 6ix</title>
<link>https://6ix.com/company/cosmos-health-inc</link>
<description>Latest news and press releases for Cosmos Health Inc. on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Tue, 21 Apr 2026 04:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/cosmos-health-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835586478dffbe2df0ea956.webp</url>
<title>Cosmos Health Inc.</title>
<link>https://6ix.com/company/cosmos-health-inc</link>
</image>
<item>
<title>Cosmos Health Introduces the "18 Series" in the United States - A Science-Driven Nutraceutical Platform Built on Patented Ingredients, Published Clinical Research, and Exact Clinical Dosing; Targeting a Portfolio of 18 Clinically Validated Products</title>
<link>https://6ix.com/company/cosmos-health-inc/news/cosmos-health-introduces-the-18-series-in-the-united-states-a-science-driven-nutraceutical-platform-built-on-patented-ingredients-published-clinical-research-and-exact-clinical-dosing-targeting-a-portfolio-of-18-clinically-validated-products-1</link>
<guid isPermaLink="true">https://6ix.com/company/cosmos-health-inc/news/cosmos-health-introduces-the-18-series-in-the-united-states-a-science-driven-nutraceutical-platform-built-on-patented-ingredients-published-clinical-research-and-exact-clinical-dosing-targeting-a-portfolio-of-18-clinically-validated-products-1</guid>
<pubDate>Tue, 21 Apr 2026 04:00:00 GMT</pubDate>
<description>Science-first nutraceutical platform: Every "18" product must clear three criteria before reaching market - a patented ingredient, peer-reviewed clinical</description>
</item>
<item>
<title>Cosmos Health Accelerates U.S. Expansion: Liv18 Phase 1 Execution Complete; Production and Sales Commencing April 2026; Expected to Generate $5M+ in Annual Revenue at ~75% Gross Margins; Early U.S. Commercial Traction Observed Across Product Portfolio</title>
<link>https://6ix.com/company/cosmos-health-inc/news/cosmos-health-accelerates-us-expansion-liv18-phase-1-execution-complete-production-and-sales-commencing-april-2026-expected-to-generate-dollar5m-in-annual-revenue-at-75percent-gross-margins-early-us-commercial-traction-observed-across-product-portfolio</link>
<guid isPermaLink="true">https://6ix.com/company/cosmos-health-inc/news/cosmos-health-accelerates-us-expansion-liv18-phase-1-execution-complete-production-and-sales-commencing-april-2026-expected-to-generate-dollar5m-in-annual-revenue-at-75percent-gross-margins-early-us-commercial-traction-observed-across-product-portfolio</guid>
<pubDate>Mon, 20 Apr 2026 14:55:00 GMT</pubDate>
<description>Phase 1 complete: product development, packaging, and initial commercial setup finalized ahead of schedule Production commencing April 2026: GMP-certified, FDA-registered, UL-audited U.S. manufacturing - mitigating tariff risk $5M+ projected annual ...</description>
</item>
<item>
<title>Cosmos Health Continues US Expansion with Q2 Launch of Cur18 - a Clinically Studied, Patented Curcumin Next-Gen Therapy Supplement Delivering 39× Higher Bioavailability and Designed to Support Joint Health</title>
<link>https://6ix.com/company/cosmos-health-inc/news/cosmos-health-continues-us-expansion-with-q2-launch-of-cur18-a-clinically-studied-patented-curcumin-next-gen-therapy-supplement-delivering-39-higher-bioavailability-and-designed-to-support-joint-health</link>
<guid isPermaLink="true">https://6ix.com/company/cosmos-health-inc/news/cosmos-health-continues-us-expansion-with-q2-launch-of-cur18-a-clinically-studied-patented-curcumin-next-gen-therapy-supplement-delivering-39-higher-bioavailability-and-designed-to-support-joint-health</guid>
<pubDate>Fri, 17 Apr 2026 18:00:00 GMT</pubDate>
<description>Clinically studied curcumin formulation demonstrating significantly enhanced absorption versus standard 95% curcuminoid extracts. Derived predominantly from turmeric (~98.5%), maintaining a composition closer to the natural profile of the plant. Utilizes ...</description>
</item>
<item>
<title>Cosmos Health Advances AI Investments to Enhance Efficiency, Reduce Costs, Improve Customer Experience and Drive Sales Growth; Certain Operating Expenses May Decrease by Up to 30%</title>
<link>https://6ix.com/company/cosmos-health-inc/news/cosmos-health-advances-ai-investments-to-enhance-efficiency-reduce-costs-improve-customer-experience-and-drive-sales-growth-certain-operating-expenses-may-decrease-by-up-to-30percent</link>
<guid isPermaLink="true">https://6ix.com/company/cosmos-health-inc/news/cosmos-health-advances-ai-investments-to-enhance-efficiency-reduce-costs-improve-customer-experience-and-drive-sales-growth-certain-operating-expenses-may-decrease-by-up-to-30percent</guid>
<pubDate>Thu, 16 Apr 2026 19:15:00 GMT</pubDate>
<description>CHICAGO, IL / ACCESS Newswire / April 16, 2026 / Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group, today announced the continued integration of artificial intelligence ...</description>
</item>
<item>
<title>Cosmos Health Reports Full Year 2025 Results: Revenue Hits All-Time Record of $65.3M, Up 20%; Gross Profit Surges 83% to $7.9M; Gross Margin Expands 418 Basis Points; Adjusted EPS Improves 82%; Cash Position Up 10x to $3.5M; Record Growth Continues Into 2026 Across All Core Segments</title>
<link>https://6ix.com/company/cosmos-health-inc/news/cosmos-health-reports-full-year-2025-results-revenue-hits-all-time-record-of-dollar653m-up-20percent-gross-profit-surges-83percent-to-dollar79m-gross-margin-expands-418-basis-points-adjusted-eps-improves-82percent-cash-position-up-10x-to-dollar35m-record-growth-continues-into-2026-across-all-core-segments</link>
<guid isPermaLink="true">https://6ix.com/company/cosmos-health-inc/news/cosmos-health-reports-full-year-2025-results-revenue-hits-all-time-record-of-dollar653m-up-20percent-gross-profit-surges-83percent-to-dollar79m-gross-margin-expands-418-basis-points-adjusted-eps-improves-82percent-cash-position-up-10x-to-dollar35m-record-growth-continues-into-2026-across-all-core-segments</guid>
<pubDate>Wed, 15 Apr 2026 13:25:00 GMT</pubDate>
<description>Scaled contract manufacturing division, securing long-term agreements for over 12 million units Expanded Sky Premium Life portfolio by 60 SKUs and accelerated global expansion, securing purchase orders for over 300,000 units across new markets Advanced ...</description>
</item>
<item>
<title>Cosmos Health Receives Third Consecutive Purchase Order from Pharmalink for 60,000 Units of Sky Premium Life Products in the UAE; Cumulative Orders Reach 270,000 Units, Advancing 5-Year Goal of Over 3 million Units</title>
<link>https://6ix.com/company/cosmos-health-inc/news/cosmos-health-receives-third-consecutive-purchase-order-from-pharmalink-for-60000-units-of-sky-premium-life-products-in-the-uae-cumulative-orders-reach-270000-units-advancing-5-year-goal-of-over-3-million-units</link>
<guid isPermaLink="true">https://6ix.com/company/cosmos-health-inc/news/cosmos-health-receives-third-consecutive-purchase-order-from-pharmalink-for-60000-units-of-sky-premium-life-products-in-the-uae-cumulative-orders-reach-270000-units-advancing-5-year-goal-of-over-3-million-units</guid>
<pubDate>Mon, 13 Apr 2026 04:00:00 GMT</pubDate>
<description>CHICAGO, IL / ACCESS Newswire / April 13, 2026 / Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated</description>
</item>
<item>
<title>Cosmos Health Reports No Impact from Iran and Middle East Conflict; Revenue Continues at All-Time High Levels; NOOR U.S. Expansion on Track to Exceed $12 Million Within 12 Months</title>
<link>https://6ix.com/company/cosmos-health-inc/news/cosmos-health-reports-no-impact-from-iran-and-middle-east-conflict-revenue-continues-at-all-time-high-levels-noor-us-expansion-on-track-to-exceed-dollar12-million-within-12-months</link>
<guid isPermaLink="true">https://6ix.com/company/cosmos-health-inc/news/cosmos-health-reports-no-impact-from-iran-and-middle-east-conflict-revenue-continues-at-all-time-high-levels-noor-us-expansion-on-track-to-exceed-dollar12-million-within-12-months</guid>
<pubDate>Fri, 10 Apr 2026 04:00:00 GMT</pubDate>
<description>CHICAGO, IL / ACCESS Newswire / April 10, 2026 / Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated</description>
</item>
<item>
<title>Cosmos Health Continues Expansion in the United States with Q2 Launch of Liv18 - a Clinically Proven, Patented Supplement for Liver Fat Reduction</title>
<link>https://6ix.com/company/cosmos-health-inc/news/cosmos-health-continues-expansion-in-the-united-states-with-q2-launch-of-liv18-a-clinically-proven-patented-supplement-for-liver-fat-reduction</link>
<guid isPermaLink="true">https://6ix.com/company/cosmos-health-inc/news/cosmos-health-continues-expansion-in-the-united-states-with-q2-launch-of-liv18-a-clinically-proven-patented-supplement-for-liver-fat-reduction</guid>
<pubDate>Wed, 08 Apr 2026 04:00:00 GMT</pubDate>
<description>Powered by BergacynFF®, the only patented botanical blend clinically demonstrated to reduce liver fat accumulation and support healthy body weight in two</description>
</item>
<item>
<title>Cosmos Health Announces Successful EN 12791 Study Results for C-Scrub Wash 4%, Strengthening Expansion into Hospital and Surgical Markets</title>
<link>https://6ix.com/company/cosmos-health-inc/news/cosmos-health-announces-successful-en-12791-study-results-for-c-scrub-wash-4percent-strengthening-expansion-into-hospital-and-surgical-markets-7</link>
<guid isPermaLink="true">https://6ix.com/company/cosmos-health-inc/news/cosmos-health-announces-successful-en-12791-study-results-for-c-scrub-wash-4percent-strengthening-expansion-into-hospital-and-surgical-markets-7</guid>
<pubDate>Wed, 01 Apr 2026 04:00:00 GMT</pubDate>
<description>CHICAGO, IL / ACCESS Newswire / April 1, 2026 / Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated</description>
</item>
<item>
<title>Cosmos Health Provides Update; Evaluates Options to Address Valuation Disconnect; Will Issue Updated Guidance Following FY 2025 Results; Record Growth Continues as Significant U.S. Expansion Underway, with Additional $12M+ in High-Margin Revenue Projected; Important R&D Updates Expected Following Finalization of Certain Anticipated Transactions</title>
<link>https://6ix.com/company/cosmos-health-inc/news/cosmos-health-provides-update-evaluates-options-to-address-valuation-disconnect-will-issue-updated-guidance-following-fy-2025-results-record-growth-continues-as-significant-us-expansion-underway-with-additional-dollar12m-in-high-margin-revenue-projected-important-randd-updates-expected-following-finalization-of-certain-anticipated-transactions</link>
<guid isPermaLink="true">https://6ix.com/company/cosmos-health-inc/news/cosmos-health-provides-update-evaluates-options-to-address-valuation-disconnect-will-issue-updated-guidance-following-fy-2025-results-record-growth-continues-as-significant-us-expansion-underway-with-additional-dollar12m-in-high-margin-revenue-projected-important-randd-updates-expected-following-finalization-of-certain-anticipated-transactions</guid>
<pubDate>Thu, 19 Mar 2026 16:45:00 GMT</pubDate>
<description>Continues to deliver record revenue and improving operating metricsSignificant expansion in the United States underway, with NOOR and other Sky Premium Life products expected to drive strong profitability supported by gross margins of approximately 75%NOOR Collagen alone is projected to generate more than $12 million in annualized revenue Strong growth expected ahead, driven by organic progress and M&A pipeline including a recent LOI to acquire an $11.5 million pharmacy distribution network Hold</description>
</item>
<item>
<title>Cosmos Health Provides Update; Evaluates Options to Address Valuation Disconnect; Will Issue Updated Guidance Following FY 2025 Results; Record Growth Continues as Significant U.S. Expansion Underway, with Additional $12M+ in High-Margin Revenue Proje...</title>
<link>https://6ix.com/company/cosmos-health-inc/news/cosmos-health-provides-update-evaluates-options-to-address-valuation-disconnect-will-issue-updated-guidance-following-fy-2025-results-record-growth-continues-as-significant-us-expansion-underway-with-additional-dollar12m-in-high-margin-revenue-proje</link>
<guid isPermaLink="true">https://6ix.com/company/cosmos-health-inc/news/cosmos-health-provides-update-evaluates-options-to-address-valuation-disconnect-will-issue-updated-guidance-following-fy-2025-results-record-growth-continues-as-significant-us-expansion-underway-with-additional-dollar12m-in-high-margin-revenue-proje</guid>
<pubDate>Thu, 19 Mar 2026 04:00:00 GMT</pubDate>
<description>Cosmos Health Provides Update; Evaluates Options to Address Valuation Disconnect; Will Issue Updated Guidance Following FY 2025 Results; Record Growth</description>
</item>
<item>
<title>Cosmos Health Purchases $600,000 of Bitcoin, Expands Digital Asset Holdings to $3,100,000</title>
<link>https://6ix.com/company/cosmos-health-inc/news/cosmos-health-purchases-dollar600000-of-bitcoin-expands-digital-asset-holdings-to-dollar3100000</link>
<guid isPermaLink="true">https://6ix.com/company/cosmos-health-inc/news/cosmos-health-purchases-dollar600000-of-bitcoin-expands-digital-asset-holdings-to-dollar3100000</guid>
<pubDate>Wed, 11 Mar 2026 04:00:00 GMT</pubDate>
<description>CHICAGO, March 11, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global</description>
</item>
<item>
<title>Cosmos Health Enters into LOI to Acquire $11,500,000 Pharmacy Distribution Network; Remains on Track to Deliver 2027 Revenue Guidance of $155,800,000</title>
<link>https://6ix.com/company/cosmos-health-inc/news/cosmos-health-enters-into-loi-to-acquire-dollar11500000-pharmacy-distribution-network-remains-on-track-to-deliver-2027-revenue-guidance-of-dollar155800000-22</link>
<guid isPermaLink="true">https://6ix.com/company/cosmos-health-inc/news/cosmos-health-enters-into-loi-to-acquire-dollar11500000-pharmacy-distribution-network-remains-on-track-to-deliver-2027-revenue-guidance-of-dollar155800000-22</guid>
<pubDate>Tue, 10 Mar 2026 04:00:00 GMT</pubDate>
<description>CHICAGO, Ill., March 10, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated</description>
</item>
<item>
<title>Cosmos Health Appoints Globally Recognized AI-Driven Drug Discovery and Clinical-Stage Biotech Expert Dr. Dimitrios Iliopoulos to Advisory Board</title>
<link>https://6ix.com/company/cosmos-health-inc/news/cosmos-health-appoints-globally-recognized-ai-driven-drug-discovery-and-clinical-stage-biotech-expert-dr-dimitrios-iliopoulos-to-advisory-board</link>
<guid isPermaLink="true">https://6ix.com/company/cosmos-health-inc/news/cosmos-health-appoints-globally-recognized-ai-driven-drug-discovery-and-clinical-stage-biotech-expert-dr-dimitrios-iliopoulos-to-advisory-board</guid>
<pubDate>Tue, 24 Feb 2026 17:30:00 GMT</pubDate>
<description>CHICAGO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced the appointment of Dr. Dimitrios Iliopoulos to its Advisory Board, where he will support the Company’s biotechnology initiatives, with a focus on AI-driven drug discovery and clinical-stage therapeutic development. Dr. Iliopoulos is a world-renowned expert in artificial intelligence, drug discovery, and drug</description>
</item>
<item>
<title>Cosmos Health Highlights Approximately $15 Million Fair Market Value of Real Estate Assets, Exceeding Current Market Capitalization; Evaluates Monetization Options to Address Significant Discount to Book Value</title>
<link>https://6ix.com/company/cosmos-health-inc/news/cosmos-health-highlights-approximately-dollar15-million-fair-market-value-of-real-estate-assets-exceeding-current-market-capitalization-evaluates-monetization-options-to-address-significant-discount-to-book-value</link>
<guid isPermaLink="true">https://6ix.com/company/cosmos-health-inc/news/cosmos-health-highlights-approximately-dollar15-million-fair-market-value-of-real-estate-assets-exceeding-current-market-capitalization-evaluates-monetization-options-to-address-significant-discount-to-book-value</guid>
<pubDate>Thu, 19 Feb 2026 16:30:00 GMT</pubDate>
<description>CHICAGO, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today highlighted the intrinsic value of its wholly owned real estate portfolio and announced that it is evaluating strategic monetization options to unlock shareholder value. Based on independent valuation reports, recent market data, and comparable transactions, management estimates the combined fair market value of the Co</description>
</item>
<item>
<title>Cosmos Health Announces Growing Momentum for C-Scrub in the United Kingdom; Now Available at Tesco, the UK’s Largest Retailer</title>
<link>https://6ix.com/company/cosmos-health-inc/news/cosmos-health-announces-growing-momentum-for-c-scrub-in-the-united-kingdom-now-available-at-tesco-the-uks-largest-retailer</link>
<guid isPermaLink="true">https://6ix.com/company/cosmos-health-inc/news/cosmos-health-announces-growing-momentum-for-c-scrub-in-the-united-kingdom-now-available-at-tesco-the-uks-largest-retailer</guid>
<pubDate>Wed, 18 Feb 2026 15:17:00 GMT</pubDate>
<description>CHICAGO, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced a significant expansion of its United Kingdom (UK) retail footprint as its antimicrobial skin cleanser, C-Scrub Wash Chlorhexidine 4% (“C-Scrub”), is now available through Tesco, the UK’s largest retailer. Tesco is a leading multinational retail group operating across multiple markets and ranked among the top</description>
</item>
<item>
<title>Cosmos Health Continues UK Retail Expansion for C-Scrub; Now Available at Superdrug, the UK’s Second-Largest Beauty and Health Retailer</title>
<link>https://6ix.com/company/cosmos-health-inc/news/cosmos-health-continues-uk-retail-expansion-for-c-scrub-now-available-at-superdrug-the-uks-second-largest-beauty-and-health-retailer</link>
<guid isPermaLink="true">https://6ix.com/company/cosmos-health-inc/news/cosmos-health-continues-uk-retail-expansion-for-c-scrub-now-available-at-superdrug-the-uks-second-largest-beauty-and-health-retailer</guid>
<pubDate>Wed, 18 Feb 2026 05:00:00 GMT</pubDate>
<description>CHICAGO, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global</description>
</item>
<item>
<title>Cosmos Health Showcases Expanding Brand Portfolio at World Health Expo Dubai 2026</title>
<link>https://6ix.com/company/cosmos-health-inc/news/cosmos-health-showcases-expanding-brand-162500958</link>
<guid isPermaLink="true">https://6ix.com/company/cosmos-health-inc/news/cosmos-health-showcases-expanding-brand-162500958</guid>
<pubDate>Tue, 17 Feb 2026 16:25:00 GMT</pubDate>
<description>CHICAGO, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced its participation in World Health Expo Dubai 2026 (formerly Arab Health), one of the world’s largest and most influential healthcare exhibitions and conferences. The Expo was held February 9–12, 2026, at the Dubai Exhibition Centre in Expo City Dubai, United Arab Emirates, where Cosmos Health exhibited at Boo</description>
</item>
<item>
<title>Cosmos Health Expands Digital Assets Program with $500,000 Bitcoin Purchase, Bringing Total Cryptocurrency Investments to $2.5 Million; Evaluates Inclusion of Other Select Cryptocurrencies</title>
<link>https://6ix.com/company/cosmos-health-inc/news/cosmos-health-expands-digital-assets-program-with-dollar500000-bitcoin-purchase-bringing-total-cryptocurrency-investments-to-dollar25-million-evaluates-inclusion-of-other-select-cryptocurrencies</link>
<guid isPermaLink="true">https://6ix.com/company/cosmos-health-inc/news/cosmos-health-expands-digital-assets-program-with-dollar500000-bitcoin-purchase-bringing-total-cryptocurrency-investments-to-dollar25-million-evaluates-inclusion-of-other-select-cryptocurrencies</guid>
<pubDate>Wed, 11 Feb 2026 05:00:00 GMT</pubDate>
<description>CHICAGO, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global</description>
</item>
<item>
<title>Cosmos Health Announces Accelerating Customer Growth, Improving Unit Economics and Robotic Expansion Supporting $40M in Additional Annual Revenue</title>
<link>https://6ix.com/company/cosmos-health-inc/news/cosmos-health-announces-accelerating-customer-154500206</link>
<guid isPermaLink="true">https://6ix.com/company/cosmos-health-inc/news/cosmos-health-announces-accelerating-customer-154500206</guid>
<pubDate>Tue, 20 Jan 2026 15:45:00 GMT</pubDate>
<description>CHICAGO, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced continued operational growth and infrastructure expansion at Cosmofarm, its pharmaceutical distribution subsidiary in Greece. During 2025, Cosmofarm added nearly 100 new pharmacy customers, representing a weighted average increase of approximately 20% in its active customer base. This growth was accompanied b</description>
</item>
</channel>
</rss>